MicroRNA-513 Regulates B7-H1 Translation and Is Involved in IFN-γ-Induced B7-H1 Expression in Cholangiocytes12

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Journal of Immunology

• Publication date

  2009-02-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.4049/jimmunol.182.3.1325PMID 19155478PMCID PMC2652126
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• MicroRNA-221/222 confers tamoxifen resistance in breast cancer by targeting p27(kip1).

  2009cited by this paper
• MicroRNA targets in immune genes and the Dicer/Argonaute and ARE machinery components.

  2008influential reference
• MicroRNA-221/222 Confers Tamoxifen Resistance in Breast Cancer by Targeting p27Kip1*♦

  2008cited by this paper
• A Cellular Micro-RNA, let-7i, Regulates Toll-like Receptor 4 Expression and Contributes to Cholangiocyte Immune Responses against Cryptosporidium parvum Infection*

  2007cited by this paper
• Interferon modulation of cellular microRNAs as an antiviral mechanism

  2007cited by this paper
• Regulation of interferon-gamma during innate and adaptive immune responses.

  2007cited by this paper
• Cell type-specific signaling in response to interferon-gamma.

  2007cited by this paper
• Survivin and B7-H1 Are Collaborative Predictors of Survival and Represent Potential Therapeutic Targets for Patients with Renal Cell Carcinoma

  2007cited by this paper
• Altered retinal microRNA expression profile in a mouse model of retinitis pigmentosa

  2007cited by this paper
• STAT activation and differential complex formation dictate selectivity of interferon responses.

  2007cited by this paper
• Expression of PD-1, PD-L1, and PD-L2 in the Liver in Autoimmune Liver Diseases

  2007cited by this paper
• Cell Type-Specific Signaling in Response to Interferon-γ

  2007cited by this paper
• MicroRNAs and immunity: tiny players in a big field.

  2007cited by this paper
• miRNA Profiling of Naïve, Effector and Memory CD8 T Cells

  2007cited by this paper
• The B7 Family and Cancer Therapy: Costimulation and Coinhibition

  2007cited by this paper
• Biliary atresia--translational research on key molecular processes regulating biliary injury and obstruction.

  2006cited by this paper
• PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression

  2006cited by this paper
• NF-κB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses

  2006cited by this paper
• A sensitive array for microRNA expression profiling (miChip) based on locked nucleic acids (LNA).

  2006cited by this paper
• Expression of B7-H1 on Gastric Epithelial Cells: Its Potential Role in Regulating T Cells during Helicobacter pylori Infection1

  2006cited by this paper
• Immunoregulatory role of B7-H1 in chronicity of inflammatory responses.

  2006cited by this paper
• Interferon-gamma down-regulates transcription of the mu-opioid receptor gene in neuronal and immune cells.

  2006cited by this paper
• Interferon‐γ down‐regulates expression of the 230‐kDa bullous pemphigoid antigen gene (BPAG1) in epidermal keratinocytes via novel chimeric sequences of ISRE and GAS

  2006cited by this paper
• Interferon-γ down-regulates transcription of the μ-opioid receptor gene in neuronal and immune cells

  2006cited by this paper
• Differential Role of Programmed Death-Ligand 1 and Programmed Death-Ligand 2 in Regulating the Susceptibility and Chronic Progression of Experimental Autoimmune Encephalomyelitis1

  2006cited by this paper
• PD-L1 is expressed by human renal tubular epithelial cells and suppresses T cell cytokine synthesis.

  2005influential reference
• RAS is regulated by the let-7 microRNA family.

  2005cited by this paper
• Pathophysiology of cholangiopathies.

  2005cited by this paper
• Biliary epithelial cells regulate autoreactive T cells: Implications for biliary‐specific diseases

  2005cited by this paper
• The Pathophysiology of Biliary Epithelia

  2004cited by this paper
• The cholangiopathies: disorders of biliary epithelia.

  2004cited by this paper
• Intensified Cloning Efforts Have Revealed Numer

  2004influential reference
• Fas induces apoptosis in human coronary artery endothelial cells in vitro

  2004cited by this paper
• B7-H1 determines accumulation and deletion of intrahepatic CD8(+) T lymphocytes.

  2004cited by this paper
• The functions of animal microRNAs

  2004cited by this paper
• Prediction of mammalian microRNA targets.

  2003cited by this paper
• The pathobiology of biliary epithelia

  2002cited by this paper
• Tumor-associated B7-H1 promotes T-cell apoptosis: A potential mechanism of immune evasion

  2002cited by this paper
• Expression of Programmed Death 1 Ligands by Murine T Cells and APC1

  2002cited by this paper
• Cryptosporidium parvum induces apoptosis in biliary epithelia by a Fas/Fas ligand-dependent mechanism.

  1999cited by this paper
• Cryptosporidium parvum induces apoptosis in biliary epithelia by a Fas/Fas ligand-dependent mechanism.

  1999cited by this paper
• STATs and gene regulation.

  1997cited by this paper
• Regulation of intracellular pH by immortalized human intrahepatic biliary epithelial cell lines.

  1994cited by this paper

• Complex regulatory network of programmed death-ligand 1 in cancer: Cancer immunomodulation from molecular mechanisms to clinical applications

  2025cites this paper
• Nanomedicine targeting the PD-1/PD-L1 axis in autoimmune diseases: breaking conventional barriers to restore immune tolerance

  2025cites this paper
• A novel basement membrane-related gene signature predicts prognosis and immunotherapy response in hepatocellular carcinoma

  2024cites this paper
• Insights into the genetic and epigenetic mechanisms governing X-chromosome-linked-miRNAs expression in cancer; a step-toward ncRNA precision.

  2024cites this paper
• miR-181d targets BCL2 to regulate HCT-8 cell apoptosis and parasite burden in response to Cryptosporidium parvum infection via the intrinsic apoptosis pathway.

  2024cites this paper
• Immunotherapy outcomes in non-small cell lung cancer according to a gender perspective.

  2024cites this paper
• Lnc-CCNH-8 promotes immune escape by up-regulating PD-L1 in hepatocellular carcinoma

  2024cites this paper
• Role of regulation of PD-1 and PD-L1 expression in sepsis

  2023cites this paper
• PD-L1: expression regulation

  2023cites this paper
• Cholangiokines: undervalued modulators in the hepatic microenvironment

  2023cites this paper
• Current Understanding on Why Ovarian Cancer Is Resistant to Immune Checkpoint Inhibitors

  2023cites this paper
• A fatty acid-rich fraction of an endolichenic fungus Phoma sp. suppresses immune checkpoint markers via AhR/ARNT and ESR1

  2023cites this paper
• Connecting the mechanisms of tumor sex differences with cancer therapy

  2023cites this paper
• The opportunities and challenges in immunotherapy: Insights from the regulation of PD-L1 in cancer cells

  2023cites this paper
• MiR-3976 regulates HCT-8 cell apoptosis and parasite burden by targeting BCL2A1 in response to Cryptosporidium parvum infection

  2023cites this paper
• Role of tumor microenvironment in cancer progression and therapeutic strategy

  2023cites this paper
• Diagnostic Predictors of Immunotherapy Response in Head and Neck Squamous Cell Carcinoma

  2023cites this paper
• PD-1/PD-L1 axis in organ fibrosis

  2023cites this paper
• Role of non-coding RNA in immune microenvironment and anticancer therapy of gastric cancer

  2022cites this paper
• Beyond Cancer: Regulation and Function of PD-L1 in Health and Immune-Related Diseases

  2022cites this paper
• Current insight into the regulation of PD-L1 in cancer

  2022cites this paper
• Over-Expression of GUSB Leads to Primary Resistance of Anti-PD1 Therapy in Hepatocellular Carcinoma

  2022cites this paper
• DENR controls JAK2 translation to induce PD-L1 expression for tumor immune evasion

  2022cites this paper
• Inhibition of PARP Potentiates Immune Checkpoint Therapy through miR-513/PD-L1 Pathway in Hepatocellular Carcinoma

  2022cites this paper
• Mechanisms and Strategies to Overcome PD-1/PD-L1 Blockade Resistance in Triple-Negative Breast Cancer

  2022influential citation
• MicroRNAs and their role in immunogenetic-dysregulation

  2022cites this paper
• Mechanisms regulating PD-L1 expression in cancers and associated opportunities for novel small-molecule therapeutics

  2022cites this paper
• A Novel Hypoxic-Angiogenesis-Immune-Related Gene Model for Prognostic and Therapeutic Effect Prediction in Hepatocellular Carcinoma Patients

  2022cites this paper
• Programmed Cell Death-Ligand 1 in Head and Neck Squamous Cell Carcinoma: Molecular Insights, Preclinical and Clinical Data, and Therapies

  2022cites this paper
• Generation, secretion and degradation of cancer immunotherapy target PD-L1

  2022cites this paper
• Cancer-Associated Fibroblasts Promote the Upregulation of PD-L1 Expression Through Akt Phosphorylation in Colorectal Cancer

  2021cites this paper
• Radiomics Study for Predicting the Expression of PD-L1 and Tumor Mutation Burden in Non-Small Cell Lung Cancer Based on CT Images and Clinicopathological Features

  2021cites this paper
• The generation of PD-L1 and PD-L2 in cancer cells: From nuclear chromatin reorganization to extracellular presentation

  2021cites this paper
• Regulatory mechanisms of immune checkpoints PD-L1 and CTLA-4 in cancer

  2021cites this paper
• Atorvastatin Attenuates Programmed Death Ligand-1 (PD-L1) Induction in Human Hepatocellular Carcinoma Cells

  2021cites this paper
• Biology of splenic and nodal marginal zone lymphomas

  2021cites this paper
• Role of the PD‐1/PD‐L1 Signaling in Multiple Sclerosis and Experimental Autoimmune Encephalomyelitis: Recent Insights and Future Directions

  2021cites this paper
• Pan-cancer landscape of CD274 (PD-L1) rearrangements in 283,050 patient samples, its correlation with PD-L1 protein expression, and immunotherapy response

  2021cites this paper
• Clinical characteristics of gastrointestinal immune-related adverse events of immune checkpoint inhibitors and their association with survival

  2021cites this paper
• Oleuropin controls miR-194/XIST/PD-L1 loop in triple negative breast cancer: New role of nutri-epigenetics in immune-oncology.

  2021cites this paper
• Expression of PD-L1 in EBV-associated malignancies.

  2021cites this paper
• The Role of Oncogenes and Redox Signaling in the Regulation of PD-L1 in Cancer

  2021cites this paper
• WSX1 act as a tumor suppressor in hepatocellular carcinoma by downregulating neoplastic PD-L1 expression

  2021cites this paper
• The Inhibitory Mechanisms of Tumor PD-L1 Expression by Natural Bioactive Gallic Acid in Non-Small-Cell Lung Cancer (NSCLC) Cells

  2020cites this paper
• Cryptosporidium: Methods and Protocols

  2020cites this paper
• Programmed Death Ligand-1 (PD-L1) Regulated by NRF-2/MicroRNA-1 Regulatory Axis Enhances Drug Resistance and Promotes Tumorigenic Properties in Sorafenib-Resistant Hepatoma Cells

  2020cites this paper
• An update of knowledge on PD-L1 in head and neck cancers: Physiologic, prognostic and therapeutic perspectives.

  2020cites this paper
• Co-Regulation of Immune Checkpoint PD-L1 with Interferon-Gamma Signaling is Associated with a Survival Benefit in Renal Cell Cancer

  2020cites this paper
• Pivotal role of PD-1/PD-L1 immune checkpoints in immune escape and cancer progression: their interplay with platelets and FOXP3+Tregs related molecules, clinical implications and combinational potential with phytochemicals.

  2020cites this paper
• MicroRNA‐200b is a potential biomarker of the expression of PD‐L1 in patients with lung cancer

  2020cites this paper
• Use of miRNAs to Study Host Cell-Parasite Interactions.

  2020cites this paper
• Immunomodulatory role for MicroRNAs: Regulation of PD-1/PD-L1 and CTLA-4 immune checkpoints expression.

  2020cites this paper
• Regulation of PD-L1 expression in cancer and clinical implications in immunotherapy.

  2020cites this paper
• Regulation of PD-L1 expression in K-ras-driven cancers through ROS-mediated FGFR1 signaling

  2020cites this paper
• Programmed cell death ligand‐1: A dynamic immune checkpoint in cancer therapy

  2020cites this paper
• Soluble PD-1: Predictive, Prognostic, and Therapeutic Value for Cancer Immunotherapy

  2020cites this paper
• How microRNAs affect the PD-L1 and its synthetic pathway in cancer.

  2020cites this paper
• Roles of PD-1/PD-L1 Pathway: Signaling, Cancer, and Beyond.

  2020cites this paper
• Spatial and Temporal Changes in PD-L1 Expression in Cancer: The Role of Genetic Drivers, Tumor Microenvironment and Resistance to Therapy

  2020cites this paper
• Molecular mechanisms of breast cancer chemoresistance by immune checkpoints.

  2020cites this paper
• MicroRNA-375 reverses the expression of PD-L1 by inactivating the JAK2/STAT3 signaling pathways in gastric cancer.

  2020cites this paper
• Non-coding RNA and immune-checkpoint inhibitors: friends or foes?

  2020cites this paper
• A Feedback Loop Formed by ATG7/Autophagy, FOXO3a/miR-145 and PD-L1 Regulates Stem-Like Properties and Invasion in Human Bladder Cancer

  2019cites this paper
• Title Clinical Impact of Single Nucleotide Polymorphism in PD-L 1 on Response to Nivolumab for Advanced Non-Small-Cell Lung Cancer Patients

  2019cites this paper
• MiR-873/PD-L1 axis regulates the stemness of breast cancer cells

  2019cites this paper
• Downregulation of miR-146a inhibits influenza A virus replication by enhancing the type I interferon response in vitro and in vivo.

  2019cites this paper
• LIN28/let-7/PD-L1 Pathway as a Target for Cancer Immunotherapy

  2019cites this paper
• Regulation of PD-1/PD-L1 Pathway in Cancer by Noncoding RNAs

  2019cites this paper
• Recent Findings in the Regulation of Programmed Death Ligand 1 Expression

  2019cites this paper
• microRNAs Are Key Regulators in Chronic Lung Disease: Exploring the Vital Link between Disease Progression and Lung Cancer

  2019cites this paper
• YY1 regulates cancer cell immune resistance by modulating PD-L1 expression.

  2019cites this paper
• Immunomodulatory MicroRNAs in cancer: targeting immune checkpoints and the tumor microenvironment

  2019cites this paper
• IFN-gamma-induced PD-L1 expression in melanoma depends on p53 expression

  2019cites this paper
• MicroRNAs in Asthma and Respiratory Infections: Identifying Common Pathways

  2019cites this paper
• Role of the tumor microenvironment in PD-L1/PD-1-mediated tumor immune escape

  2019cites this paper
• The Aryl hydrocarbon receptor mediates tobacco-induced PD-L1 expression and is associated with response to immunotherapy

  2019cites this paper
• Programmed Death 1 (PD1)-Mediated T-Cell Apoptosis and Cancer Immunotherapy

  2018cites this paper
• Genetic, transcriptional and post-translational regulation of the programmed death protein ligand 1 in cancer: biology and clinical correlations

  2018cites this paper
• MicroRNA-140 suppresses osteosarcoma tumor growth by enhancing anti-tumor immune response and blocking mTOR signaling.

  2018cites this paper
• Gene code CD274/PD-L1: from molecular basis toward cancer immunotherapy

  2018cites this paper
• Regulation and Function of the PD-L1 Checkpoint.

  2018cites this paper
• The intracellular signalosome of PD-L1 in cancer cells

  2018cites this paper
• Targeting PD-L1 Protein: Translation, Modification and Transport.

  2018cites this paper
• PD‐1/PD‐L1 immune checkpoint: Potential target for cancer therapy

  2018cites this paper
• MicroRNA-497-5p down-regulation increases PD-L1 expression in clear cell renal cell carcinoma

  2018cites this paper
• MicroRNAs and their role in environmental chemical carcinogenesis

  2018cites this paper
• Type 1 IFN and PD-L1 Coordinate Lymphatic Endothelial Cell Expansion and Contraction during an Inflammatory Immune Response

  2018cites this paper
• Key questions about the checkpoint blockade-are microRNAs an answer?

  2018cites this paper
• Clinical relevance of PD‐L1 expression in gallbladder cancer: a potential target for therapy

  2018cites this paper
• Control of PD-L1 expression by miR-140/142/340/383 and oncogenic activation of the OCT4–miR-18a pathway in cervical cancer

  2018cites this paper
• miR-513a-5p targets Bcl-2 to promote dichlorvos induced apoptosis in HK-2 cells.

  2018cites this paper
• Genetic Screening Approaches to Cancer Driver Characterization and Synthetic Lethal Target Discovery

  2018cites this paper
• PD-L 1 and PD-1 screening and therapy in non small cell lung carcinoma

  2018cites this paper
• Regulatory mechanisms of PD-L1 expression in cancer cells

  2018cites this paper
• Main NK cell receptors and their ligands: regulation by microRNAs

  2018cites this paper
• Regulation of PD-L1: Emerging Routes for Targeting Tumor Immune Evasion

  2018cites this paper
• Gene expression and micro RNA profiling in acute pancreatitis

  2018cites this paper
• Cross-talk between TNF-α and IFN-γ signaling in induction of B7-H1 expression in hepatocellular carcinoma cells

  2018cites this paper
• Cancer RNome: Evolution and Sustenance

  2018cites this paper
• Regulation of the immune checkpoint PD-L1 by microRNAs

  2018cites this paper